Call-an-AmbulanceDr. Aviral Srivastava
Urology
Dr. Aviral Srivastava
Urology
About Doctor
Dr. Aviral Srivastava is a Gold Medalist Urologist with advanced training in comprehensive urological care from India’s premier medical institutions. He completed his MCh in Urology (Gold Medalist) from the prestigious Institute of Medical Sciences, Banaras Hindu University (BHU), after earning his MBBS (Gold Medalist) from AIIMS and MS (Gold Medalist) from BHU, and has obtained MRCS qualification (Edinburgh, UK). Grounded in evidence-based medicine and a patient-centric philosophy, Dr. Srivastava blends surgical precision with compassionate care. His academic distinction, technical expertise, and unwavering commitment to ethical practice are reflected in every aspect of his clinical work.
Experience
Dr. Aviral Srivastava is a Associate Consultant of Urology at Regency Healthcare. He has more than 3 years of working experience as a Associate Consultant in the Urology Department.
Qualification
- M.S.
- MRCS
- M.Ch (Urology)
Clinical Interests
- Endourology
- Laparoscopic and robotic urological surgery
- Renal transplantation
- Urinary stone disease (PCNL, RIRS)
- Prostate surgery (TURP)
- Uro-oncology (TURBT, radical nephrectomy)
- Male infertility
- Urethral stricture and reconstructive urology
Timings
Place: Regency Renal Science Hospital
OPD Time: 10:00 PM – 12:30 PM
Days: Monday To Saturday
Place: Regency Hospital (Tower 1)
OPD Time: 03:00 PM – 05:00 PM
Days: Monday To Saturday
Place: Regency Superspeciality Clinic
OPD Time: 06:00 PM – 08:00 PM
Days: Monday To Saturday
Place: Regency Hospital Govind Nagar
OPD Time: 12:30 PM – 02:30 PM
Days: Monday To Friday
More about
Dr. Aviral
- Accomplishments & Awards
- Publications & Research
- Medical Council Registration
- ASICON 2021- First Prize- Best Poster Award
- ASICON 2021- First Prize – Dr. C Palanivelu Best Postgraduate Paper Award
- ASICON 2021 – Second position in All India National Surgical Quiz
- ASOMACON 2021- Second prize in Poster presentation
- Fourth Position in National round of ASI-TYSA 2021
- NZUSICON 2023 – Third prize in moderated paper category
- NZUSICON 2024- Second prize in moderated poster category
- NZUSICON 2024- First prize in moderated poster category
- UAUCON 2024 – Second prize in best paper category
- UAUCON 2025- Second prize in moderated poster category
- NZUSICON 2025- First prize in CMC Best poster category
- NZUSICON 2025- Fourth position in Inter Institute Quiz
- Srivastava A, Trivedi S, Kumar U, Singh Y , Kumar L, Data S, Kumar A, Sankhwar S.N. (2025). Quality of life and cost-effectiveness of intravesical gemcitabine/docetaxel vs BCG in BCG-naïve non-muscle-invasive bladder cancer. BJU Int.
- Srivastava A, Trivedi S, Singh Y, Kumar U, Kumar L, Data S, Kumar Anil, Sankhwar S (2025). Prospective comparative evaluation of clinical efficacy and safety of Intravesical Gemcitabine-Docetaxel versus BCG in adjuvant management of BCG-naive non-muscle invasive urothelial bladder cancer in Indian population.
- Shubham N, Kumar U, Singh Y, Srivastava A, et al. Comparative analysis of TFL, Ho:YAG, and pneumatic lithotripter in mini-PCNL. Cureus. 2025.
- Kumar L, Baliyan A, Srivastava A, et al. Modified split graft using bovine pericardium in Peyronie’s disease. Urology Annals. 2025.
- Kumar A, Srivastava A, Tripathy R, et al. Urodynamic predictors of intravesical electrical stimulation in detrusor underactivity. Urol Res Pract. 2025.
- Mishra SP, Kar AG, Srivastava A, et al. PARP protein expression in breast cancer. J Mid-life Health. 2022.
- Srivastava A, Yadav H, Katiyar V. Isolated sigmoid perforation after blunt trauma: case series. Cureus. 2022.
- Agarwal A, Srivastava A, Fathima F, et al. Epidemiology of male infertility in central India. Int J Reprod Contracept Obstet Gynecol. 2022.
- UPMC – 103558
- Accomplishments & Awards
- Publications & Research
- Medical Council Registration
- ASICON 2021- First Prize- Best Poster Award
- ASICON 2021- First Prize – Dr. C Palanivelu Best Postgraduate Paper Award
- ASICON 2021 – Second position in All India National Surgical Quiz
- ASOMACON 2021- Second prize in Poster presentation
- Fourth Position in National round of ASI-TYSA 2021
- NZUSICON 2023 – Third prize in moderated paper category
- NZUSICON 2024- Second prize in moderated poster category
- NZUSICON 2024- First prize in moderated poster category
- UAUCON 2024 – Second prize in best paper category
- UAUCON 2025- Second prize in moderated poster category
- NZUSICON 2025- First prize in CMC Best poster category
- NZUSICON 2025- Fourth position in Inter Institute Quiz
- Srivastava A, Trivedi S, Kumar U, Singh Y , Kumar L, Data S, Kumar A, Sankhwar S.N. (2025). Quality of life and cost-effectiveness of intravesical gemcitabine/docetaxel vs BCG in BCG-naïve non-muscle-invasive bladder cancer. BJU Int.
- Srivastava A, Trivedi S, Singh Y, Kumar U, Kumar L, Data S, Kumar Anil, Sankhwar S (2025). Prospective comparative evaluation of clinical efficacy and safety of Intravesical Gemcitabine-Docetaxel versus BCG in adjuvant management of BCG-naive non-muscle invasive urothelial bladder cancer in Indian population.
- Shubham N, Kumar U, Singh Y, Srivastava A, et al. Comparative analysis of TFL, Ho:YAG, and pneumatic lithotripter in mini-PCNL. Cureus. 2025.
- Kumar L, Baliyan A, Srivastava A, et al. Modified split graft using bovine pericardium in Peyronie’s disease. Urology Annals. 2025.
- Kumar A, Srivastava A, Tripathy R, et al. Urodynamic predictors of intravesical electrical stimulation in detrusor underactivity. Urol Res Pract. 2025.
- Mishra SP, Kar AG, Srivastava A, et al. PARP protein expression in breast cancer. J Mid-life Health. 2022.
- Srivastava A, Yadav H, Katiyar V. Isolated sigmoid perforation after blunt trauma: case series. Cureus. 2022.
- Agarwal A, Srivastava A, Fathima F, et al. Epidemiology of male infertility in central India. Int J Reprod Contracept Obstet Gynecol. 2022.
- UPMC – 103558
